Quarterly
Annual
| Unit: USD | 2024-03-31 | 2023-12-31 |
|---|---|---|
operating expenses: | ||
research and development | 1,091,000 | |
general and administrative | 1,914,000 | |
total operating expenses | 3,005,000 | |
income from operations | -3,005,000 | |
yoy | ||
qoq | ||
operating margin % | ||
other income: | ||
foreign currency gain | -33,000 | |
interest income | 1,341,000 | |
total other income | 1,308,000 | |
net income | -1,697,000 | |
yoy | ||
qoq | ||
net income margin % | ||
net income per share | -0.06 | |
weighted-average number of shares outstanding used to compute net income per share, basic and diluted | 27,638,528 | |
comprehensive loss: | ||
other comprehensive income: | ||
unrealized gain on investments, net of tax of 0 | 2 | |
comprehensive loss | -1,695 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.